DOI QR코드

DOI QR Code

Lacidipine 함유 Gelucire 고체분산체의 물성 및 방출

Physical Properties of Gelucire-based Solid Dispersions Containing Lacidipine and Release Profiles

  • 발행 : 2010.02.20

초록

Lacidipine used for the treatment of hypertension has low water solubility and is classified as BCS Class II category. Gelucire-based solid dispersions (SD) containing lacidipine were prepared by solvent evaporation method to enhance drug dissolution. The powdered forms of SD showed irregularly spherical shape. Thermal behaviors of SD from differential scanning calorimetry indicated that distinct endothermic peak of lacidipine ($184^{\circ}C$) was shifted to lower region ($150.1^{\circ}C$). Drug was present in a crystalline form. NMR spectra also showed some molecular interaction between drug and Gelucire. There was no significant difference in DSC and NMR behaviors between Gelucire 44/14 and Gelucire 50/13. The initial dissolution rate of SD-loaded tablet linearly increased both in water and in water containing 1% tween 20, and much higher than the commercial tablet, $Vaxar^{(R)}$. When the amount of SD was increased, the release rate was greater. The Gelucire 50/13 showed higher dissolution than the Gelucire 44/14. The produced solid dispersion with various kinds of excipients and making tablets, it was found that solid dispersions can increase the solubility in artificial gastric juice and finally increases dissolution rate.

키워드

참고문헌

  1. S.H. Yallkowsky, Techniques of Solubilization of Drugs, Marcel Dekker, Inc., pp. 15-157 (1981).
  2. D.Q.M. Craig, The mechanism of drug release from solid dispersion in water-soluble polymers, Int. J. Pharm., 231, 131-144 (2002). https://doi.org/10.1016/S0378-5173(01)00891-2
  3. Adamo Fini and Antonio M. Rabasco, Diclofenac salts, Solids dispersion in PEG 6000 and Gelucire 50/13, Eur. J. Pharm. Biopharm., 60, 99-111 (2005). https://doi.org/10.1016/j.ejpb.2004.11.005
  4. Mahmoud Badry and M. Fatthy, Improvement of solubility and dissolution rate of indomethacin by solid dispersions in gelucire 50/13 and PEG4000, J. Saudi. Pharmaceutical Society., 16, 117-125 (2009). https://doi.org/10.1016/j.jsps.2009.08.006
  5. N. Yuksel and Tamer Baykara, Enhanced bioavailability of piroxicam using Gelucire 44/14 and Labrasol : in vitro and in vivo evaluation, Eur. J. Pharm. Biopharm., 56, 453-459 (2003) https://doi.org/10.1016/S0939-6411(03)00142-5
  6. S.A. Barker and D.Q and M. Craig, An investigation into the structure and bioavailability of a-tocopherol dispersion in Gelucire 44/14, Js. Control. Release, 91, 477-488 (2003). https://doi.org/10.1016/S0168-3659(03)00261-X
  7. W.L. Chiou, W.L. and S. Riegelman, Pharmaceutical applications of solid dispersion systems, J. Pharm. Sci., 60, 1281-1302 (1971). https://doi.org/10.1002/jps.2600600902
  8. A. Forster, J. and I. Hempenstall, Selection of excipients for melt extrusion with two poorly water-soluble drugs by solubility parameter calculation and thermal analysis, Int. J. Pharm., 226, 147-161 (2001). https://doi.org/10.1016/S0378-5173(01)00801-8
  9. J. Patterson, A. Bary and T. Rades, physical stability and solubility of the thermotropic mesophase of fenoprofen calcium as pure drug and in a tablet formulation, Int. J. Pharm., 247, 147-157 (2002). https://doi.org/10.1016/S0378-5173(02)00402-7
  10. G. Pavel and H. Amnon, Uptake of lipophilic drugs by plasma derived isolated dhylomicrons: Linear correlation with intestinal lymphatic bioavailability, Euro. J. Pharm. Sci., 26, 394-404 (2005). https://doi.org/10.1016/j.ejps.2005.07.011
  11. R. Peter, E.D. Jo-Anne, J.B. Michael and F.H. David, In vitro hydrolysis of polyunsaturated fatty acid N-acyloxymethyl deravetives of theophylline, Int. J. Pharm., 165, 87-96 (1998). https://doi.org/10.1016/S0378-5173(98)00007-6
  12. E.A. Schmitt, K. Peck, Y. Sun and J-M. Geoffroy, Rapid, practical and predictive excipient compatibility screening using isothermal microcalorimetry, Thermochimica Acta., 380, 175-184 (2001). https://doi.org/10.1016/S0040-6031(01)00668-2
  13. "Lacidipine tablets", British Pharmacoepia, 2713-2715 (2009).
  14. M. Mosharraf and C. Nystrom, The effect of particle size and shape on the surface specific dissolution rate of micronized practically insoluble drugs, Int. J. Pharm., 122, 35-47 (1995). https://doi.org/10.1016/0378-5173(95)00033-F
  15. T. Mizoe, S. Beppu, T. Ozeki and H. Okada, One-step preparation of drug-containing microparticles to enhance the dissolution and absoption of poorly water-soluble drugs using a 4-fluid nozzle spray drier, J. Control. Release., 120,205-210 (2007). https://doi.org/10.1016/j.jconrel.2007.05.002